Coherus Oncology, Inc. (CHRS) NASDAQ

1.74

-0.05(-2.79%)

Updated at October 21 04:00PM

Currency In USD

Valuation

Market Cap158.08M
Enterprise Value302M
P/E Ratio1.12
PEG Ratio-0.05
Price/Sales Ratio1.42
Price/Book Ratio1.69
Enterprise/Revenue-0.09
Enterprise/EBITDA0.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin1.26
Operating Margin-0.98

Management Effectiveness

Return On Assets0.41
Return On Equity-2.54

Income Statement

Revenue266.96M
Revenue/Share1.23
Gross Profit149.41M
EBITDA60.94M
Net Income28.51M
Diluted EPS0.25

Balance Sheet

Total Cash237.64M
Total Cash/Share2.05
Total Debt2.41M
Total Debt/Equity0.02
Current Ratio1.44
Book Value Per Share1.03

Price History

52-Week Change98.68
52-Week High2.43
52-Week Low0.66
Moving Average 50 Days1.4
Moving Average 200 Days1.09

Statistics

Average Volume1.34M
Shares Outstanding116.23M
% Held by Institutions47.69

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A